- Advanced Research Technologies Inc.
Advanced Research Technologies Inc.
of Saint-Laurent, Quebec, Canada, has announced clinical trials for the SoftScan
optical breast imaging system. The device uses time-domain optical imaging to characterize
tumors as benign or malignant. Differences in optical signatures between tissues
indicate vascularization, cellularity, oxygen consumption, edema, fibrosis and remodeling.
The study will continue through 2006
at several North American centers and examine 600 to 950 volunteer patients age
25 to over 60. The company intends to present results in its submission to Health
Canada and the FDA to support its premarket approval application.
MORE FROM PHOTONICS MEDIA